Hyperreflective Foci and Disorganization of Retinal Inner Layers as Predictors of Visual Prognosis in Diabetic Macular Edema

Hannah Shiny R; Arsha Ressal; Sangeethaa Sangeethaa; Birinisha M

doi:10.37022/wjcmpr.v8i3.436

Authors

Hannah Shiny R Assistant Professor, Department of Ophthalmology, Sree Mookambika Institute of Medical Sciences.
Arsha Ressal Senior Resident, Department of Ophthalmology, Sree Mookambika Institute of Medical Sciences.
Sangeethaa 2nd Year Post Graduate, Department of Ophthalmology, Sree Mookambika Institute of Medical Sciences.
Birinisha M 2nd Year Post Graduate, Department of Ophthalmology, Sree Mookambika Institute of Medical Sciences.

Abstract

Background: Diabetic macular edema (DME) is a major cause of visual impairment, and optical coherence tomography biomarkers may help predict treatment outcomes. This study evaluated hyperreflective foci (HRF) and disorganization of retinal inner layers (DRIL) as predictors of visual prognosis in DME.

Methods: This prospective observational study included 80 eyes with DME treated with intravitreal anti-VEGF therapy and followed for 6 months. Best-corrected visual acuity (BCVA), central macular thickness (CMT), HRF count, DRIL extent, and other OCT biomarkers were assessed. Multivariable regression and ROC analyses were performed.

Results: Mean BCVA improved from 0.60 to 0.48 logMAR, while CMT decreased from 470.9 to 357.8 µm. DRIL extent showed a stronger correlation with 6-month BCVA than HRF count (r=0.699 vs 0.531). On multivariable analysis, DRIL extent, baseline BCVA, and ellipsoid-zone disruption independently predicted 6-month BCVA, whereas HRF count did not. DRIL showed an AUC of 0.829 for poor visual outcome.

Conclusion: DRIL appears to be a stronger prognostic OCT biomarker than HRF in DME.

Keywords:

Diabetic macular edema, DRIL, Hyperreflective foci, Optical coherence tomography, Visual prognosis

DOI

https://doi.org/10.37022/wjcmpr.v8i3.436

References

1. Yau JWY, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556–564. doi:10.2337/dc11-1909

2. Diabetic Retinopathy Clinical Research Network; Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, et al. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med. 2015;372(13):1193–1203. doi:10.1056/NEJMoa1414264

3. Diabetic Retinopathy Clinical Research Network. Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology. 2007;114(3):525–536. doi:10.1016/j.ophtha.2006.06.052

4. Bolz M, Schmidt-Erfurth U, Deak G, Mylonas G, Kriechbaum K, Scholda C. Optical coherence tomographic hyperreflective foci: a morphologic sign of lipid extravasation in diabetic macular edema. Ophthalmology. 2009;116(5):914–920. doi:10.1016/j.ophtha.2008.12.039

5. Uji A, Murakami T, Nishijima K, Akagi T, Horii T, Arakawa N, et al. Association between hyperreflective foci in the outer retina, status of photoreceptor layer, and visual acuity in diabetic macular edema. Am J Ophthalmol. 2012;153(4):710–717.e1. doi:10.1016/j.ajo.2011.08.041

6. Schreur V, Altay L, van Asten F, Groenewoud JMM, Fauser S, Klevering BJ, et al. Hyperreflective foci on optical coherence tomography associate with treatment outcome for anti-VEGF in patients with diabetic macular edema. PLoS One. 2018;13(10):e0206482. doi:10.1371/journal.pone.0206482

7. Sun JK, Lin MM, Lammer J, Prager S, Sarangi R, Silva PS, Aiello LP. Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema. JAMA Ophthalmol. 2014;132(11):1309–1316. doi:10.1001/jamaophthalmol.2014.2350

8. Sun JK, Radwan SH, Soliman AZ, Lammer J, Lin MM, Prager SG, et al. Neural retinal disorganization as a robust marker of visual acuity in current and resolved diabetic macular edema. Diabetes. 2015;64(7):2560–2570. doi:10.2337/db14-0782

9. Radwan SH, Soliman AZ, Tokarev J, Zhang L, van Kuijk FJ, Koozekanani DD. Association of disorganization of retinal inner layers with vision after resolution of center-involved diabetic macular edema. JAMA Ophthalmol. 2015;133(7):820–825. doi:10.1001/jamaophthalmol.2015.0972

10. Das R, Spence G, Hogg RE, Stevenson M, Chakravarthy U. Disorganization of inner retina and outer retinal morphology in diabetic macular edema. JAMA Ophthalmol. 2018;136(2):202–208. doi:10.1001/jamaophthalmol.2017.6256

11. Zur D, Iglicki M, Sala-Puigdollers A, Chhablani J, Lupidi M, Fraser-Bell S, et al. Disorganization of retinal inner layers as a biomarker in patients with diabetic macular oedema treated with dexamethasone implant. Acta Ophthalmol. 2020;98(2):e217–e223. doi:10.1111/aos.14230

12. Vujosevic S, Berton M, Bini S, Casciano M, Cavarzeran F, Midena E. Hyperreflective retinal spots and visual function after anti-vascular endothelial growth factor treatment in center-involving diabetic macular edema. Retina. 2016;36(7):1298–1308. doi:10.1097/IAE.0000000000000912

13. Arthi M, Sindal MD, Rashmita R. Hyperreflective foci as biomarkers for inflammation in diabetic macular edema: retrospective analysis of treatment naïve eyes from South India. Indian J Ophthalmol. 2021;69(5):1197–1202. doi:10.4103/ijo.IJO_2627_20

14. Huang CH, Yang CH, Hsieh YT, et al. Hyperreflective foci in predicting the treatment outcomes of diabetic macular oedema after anti-vascular endothelial growth factor therapy. Sci Rep. 2021;11:5103. doi:10.1038/s41598-021-84553-7

15. Tang L, Luo D, Qiu Q, Xu GT, Zhang J. Hyperreflective foci in diabetic macular edema with subretinal fluid: association with visual outcomes after anti-VEGF treatment. Ophthalmic Res. 2023;66(1):39–47. doi:10.1159/000525412